Is Sarepta Actually Competing with Marathon?

TheStreet's Adam Feuerstein writes that claims that Sarepta's (SRPT) - Get Report Duchenne muscular dystrophy drug Exondys 51 competes with Marathon's Emflaza steroid are unfounded.

This article was written by a staff member of TheStreet.